Factors that affect deceased donor liver transplantation rates in the United States in addition to the Model for End-stage Liver Disease score.

PubWeight™: 0.79‹?›

🔗 View Article (PMC 3518743)

Published in Liver Transpl on December 01, 2012

Authors

Pratima Sharma1, Douglas E Schaubel, Emily E Messersmith, Mary K Guidinger, Robert M Merion

Author Affiliations

1: Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA. pratimas@med.umich.edu

Articles cited by this

A model to predict survival in patients with end-stage liver disease. Hepatology (2001) 18.06

Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology (2003) 10.11

The survival benefit of liver transplantation. Am J Transplant (2005) 5.08

The model for end-stage liver disease (MELD). Hepatology (2007) 4.81

Disparities in liver transplantation before and after introduction of the MELD score. JAMA (2008) 4.10

MELD and PELD: application of survival models to liver allocation. Liver Transpl (2001) 3.76

Survival benefit-based deceased-donor liver allocation. Am J Transplant (2009) 2.89

Results of the first year of the new liver allocation plan. Liver Transpl (2004) 2.86

Disparity in use of orthotopic liver transplantation among blacks and whites. Liver Transpl (2004) 2.22

Analytical methods and database design: implications for transplant researchers, 2005. Am J Transplant (2006) 2.14

Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma. Arch Surg (2010) 2.01

Racial and ethnic disparities in access to liver transplantation. Liver Transpl (2010) 1.94

Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl (2004) 1.58

Geographic variation in organ availability is responsible for disparities in liver transplantation between Hispanics and Caucasians. Am J Transplant (2009) 1.47

Effect of pretransplant serum creatinine on the survival benefit of liver transplantation. Liver Transpl (2009) 1.06

Gender disparity in liver transplant waiting-list mortality: the importance of kidney function. Liver Transpl (2010) 1.03

Race and receipt of liver transplantation: location matters. Liver Transpl (2010) 0.88

Articles by these authors

Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology (2003) 10.11

Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med (2003) 8.47

The survival benefit of liver transplantation. Am J Transplant (2005) 5.08

A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index. Transplantation (2009) 4.45

US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis (2015) 3.94

Renal transplantation in elderly patients older than 70 years of age: results from the Scientific Registry of Transplant Recipients. Transplantation (2007) 3.69

Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. Transplantation (2002) 3.42

Dialysis outcomes and analysis of practice patterns suggests the dialysis schedule affects day-of-week mortality. Kidney Int (2012) 3.02

Sarcopenia and mortality after liver transplantation. J Am Coll Surg (2010) 2.75

Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology (2007) 2.72

Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg (2005) 2.64

Expanded criteria donors for kidney transplantation. Am J Transplant (2003) 2.25

Rates of solid-organ wait-listing, transplantation, and survival among residents of rural and urban areas. JAMA (2008) 2.24

Improving liver allocation: MELD and PELD. Am J Transplant (2004) 2.14

Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Hepatology (2011) 2.01

Semiparametric analysis of correlated recurrent and terminal events. Biometrics (2007) 2.00

Racial and ethnic disparities in access to liver transplantation. Liver Transpl (2010) 1.94

Association of center volume with outcome after liver and kidney transplantation. Am J Transplant (2004) 1.92

Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients. Am J Transplant (2004) 1.90

Effect of alcoholic liver disease and hepatitis C infection on waiting list and posttransplant mortality and transplant survival benefit. Hepatology (2009) 1.84

Re-weighting the model for end-stage liver disease score components. Gastroenterology (2008) 1.83

Liver transplantation and subsequent risk of cancer: findings from a Canadian cohort study. Liver Transpl (2008) 1.78

Kidneys from donors after cardiac death provide survival benefit. J Am Soc Nephrol (2010) 1.76

Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference. Clin J Am Soc Nephrol (2008) 1.76

Serum sodium and survival benefit of liver transplantation. Liver Transpl (2015) 1.75

Evaluating the survival benefit of kidney retransplantation. Transplantation (2006) 1.75

Influence of graft type on outcomes after pediatric liver transplantation. Am J Transplant (2004) 1.72

Effect of body mass index on the survival benefit of liver transplantation. Liver Transpl (2007) 1.69

Analytic morphomics, core muscle size, and surgical outcomes. Ann Surg (2012) 1.65

Laboratory test results after living liver donation in the adult-to-adult living donor liver transplantation cohort study. Liver Transpl (2011) 1.59

The rationale for the new deceased donor pancreas allocation schema. Transplantation (2007) 1.58

Who should get a liver graft? J Hepatol (2009) 1.56

Comparison of the long-term outcomes of kidney transplantation: USA versus Spain. Nephrol Dial Transplant (2012) 1.55

Intentional versus unintentional contact as a mechanism of injury in youth ice hockey. Br J Sports Med (2010) 1.51

Evidence-based development of liver allocation: a review. Transpl Int (2011) 1.50

Hepatitis C is a risk factor for death after liver retransplantation. Liver Transpl (2005) 1.48

Frailty, core muscle size, and mortality in patients undergoing open abdominal aortic aneurysm repair. J Vasc Surg (2011) 1.47

Survival on dialysis post-kidney transplant failure: results from the Scientific Registry of Transplant Recipients. Am J Kidney Dis (2007) 1.47

Satisfaction With Life Among Living Kidney Donors: A RELIVE Study of Long-Term Donor Outcomes. Transplantation (2014) 1.45

Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant (2002) 1.44

A Reassessment of the Survival Advantage of Simultaneous Kidney-Pancreas Versus Kidney-Alone Transplantation. Transplantation (2015) 1.44

Portal vein thrombosis and liver transplant survival benefit. Liver Transpl (2010) 1.42

US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis (2016) 1.37

Marginal means/rates models for multiple type recurrent event data. Lifetime Data Anal (2004) 1.37

Baseline comorbidity in kidney transplant recipients: a comparison of comorbidity indices. Am J Kidney Dis (2005) 1.32

Outcomes of donor evaluation in adult-to-adult living donor liver transplantation. Hepatology (2007) 1.31

Simulating the allocation of organs for transplantation. Health Care Manag Sci (2004) 1.31

Estimating differences in restricted mean lifetime using observational data subject to dependent censoring. Biometrics (2010) 1.25

Extracorporeal support for organ donation after cardiac death effectively expands the donor pool. J Trauma (2005) 1.22

Long-term survival after liver transplantation in children with metabolic disorders. Pediatr Transplant (2002) 1.21

Kidney transplantation and wait-listing rates from the international Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int (2005) 1.20

End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates. Hepatology (2011) 1.19

Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington, DC, USA. Liver Transpl (2004) 1.19

Pediatric transplantation, 1994-2003. Am J Transplant (2005) 1.19

The report of a national conference on the wait list for kidney transplantation. Am J Transplant (2003) 1.14

Estimating cumulative treatment effects in the presence of nonproportional hazards. Biometrics (2007) 1.11

Explaining the Relationship between Employment and Juvenile Delinquency. Criminology (2010) 1.10

Impact of the expanded criteria donor allocation system on the use of expanded criteria donor kidneys. Transplantation (2005) 1.10

Double-robust semiparametric estimator for differences in restricted mean lifetimes in observational studies. Biometrics (2012) 1.10

Epithelioid hemangioendothelioma of the liver disseminated to the peritoneum treated with liver transplantation and interferon alpha-2B. Transplantation (2002) 1.09

Enhanced training in vascular access creation predicts arteriovenous fistula placement and patency in hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study. Ann Surg (2008) 1.09

Outcomes of adult living donor liver transplantation: comparison of the Adult-to-adult Living Donor Liver Transplantation Cohort Study and the national experience. Liver Transpl (2011) 1.09

Prevalence and outcomes of multiple-listing for cadaveric kidney and liver transplantation. Am J Transplant (2004) 1.07

The effect of salvage therapy on survival in a longitudinal study with treatment by indication. Stat Med (2010) 1.06

Evaluating bias correction in weighted proportional hazards regression. Lifetime Data Anal (2008) 1.06

Effect of pretransplant serum creatinine on the survival benefit of liver transplantation. Liver Transpl (2009) 1.06

Contrasting treatment-specific survival using double-robust estimators. Stat Med (2012) 1.04

Patient-specific prediction of ESRD after liver transplantation. J Am Soc Nephrol (2013) 1.04

Organ donation and utilization in the USA. Am J Transplant (2004) 1.03

Access to renal transplantation for minority patients with ESRD in Canada. Am J Kidney Dis (2004) 1.03

Selection of pediatric candidates under the PELD system. Liver Transpl (2004) 1.01

Thoracic organ transplantation in the United States, 1994-2003. Am J Transplant (2005) 1.00

Educational web-based intervention for high school students to increase knowledge and promote positive attitudes toward organ donation. Health Educ Behav (2006) 1.00

Short-term pretransplant renal replacement therapy and renal nonrecovery after liver transplantation alone. Clin J Am Soc Nephrol (2013) 0.99

Gender imbalance and outcomes in living donor renal transplantation in the United States. Am J Transplant (2003) 0.99

Impact of the expanded criteria donor allocation system on candidates for and recipients of expanded criteria donor kidneys. Transplantation (2007) 0.99